Wealthcare Advisory Partners’s Jazz Pharmaceuticals JAZZ Stock Holding History

Wealthcare Advisory Partners’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13	Closed	-$2K	–	1169
2017 Q4	$2K	Buy	+13	New	+$1.8K	﹤0.01%	925

Other funds holding JAZZ

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SIG

Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Wealthcare Advisory Partners's JAZZ Position: Q1 2018 in Review

Wealthcare Advisory Partners sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2018, closing a stake of 13 shares — an estimated $2K sold.

Wealthcare Advisory Partners first reported a position in JAZZ in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 323 funds tracked by Wall St. Rank hold JAZZ as of Q1 2018.

Wealthcare Advisory Partners reported no remaining Jazz Pharmaceuticals position as of Q1 2018 after selling out during the quarter.
Wealthcare Advisory Partners sold 13 Jazz Pharmaceuticals shares in Q1 2018, an estimated $2K.
Wealthcare Advisory Partners first reported a position in Jazz Pharmaceuticals in Q4 2017 and held it in 1 quarter.
Wealthcare Advisory Partners's Jazz Pharmaceuticals position peaked at $2K in Q4 2017.
323 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2018.

Based on Wealthcare Advisory Partners's 13F filing for Q1 2018, filed 15 May 2018.